prazosin has been researched along with Heart Diseases in 14 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of benign prostatic hyperplasia (BPH) with nonselective alpha1 antagonists such as terazosin, doxazosin, and prazosin results in blood pressure reduction due to vasodilation." | 3.71 | Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. ( Chao, J; Chrischilles, E; Gilden, D; Kreder, KJ; Rubenstein, L; Shah, H, 2001) |
| "To evaluate the use and problems of alpha-receptor blockade with prazosin among patients in Nigeria with benign prostatic hyperplasia (BPH) who face a prolonged wait for a prostatectomy." | 3.69 | alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country. ( Ogbonna, BC; Okeahialam, BN; Ramyil, VM, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinecker, R | 1 |
| Mukharliamov, NM | 1 |
| Klein, W | 1 |
| Goebel, R | 1 |
| Gillard, C | 1 |
| Boland, J | 1 |
| Calay, G | 1 |
| Ikram, H | 1 |
| Espiner, EA | 1 |
| Chan, W | 1 |
| Nicholls, MG | 1 |
| Netz, H | 1 |
| Hagel, KJ | 1 |
| Rautenburg, HW | 1 |
| Rodrigues, B | 1 |
| Grassby, PF | 1 |
| Battell, ML | 1 |
| Lee, SY | 1 |
| McNeill, JH | 1 |
| Ogbonna, BC | 1 |
| Okeahialam, BN | 1 |
| Ramyil, VM | 1 |
| Chrischilles, E | 1 |
| Rubenstein, L | 1 |
| Chao, J | 1 |
| Kreder, KJ | 1 |
| Gilden, D | 1 |
| Shah, H | 1 |
| Enenkel, W | 1 |
| Buch, J | 1 |
| Schalekamp, MA | 1 |
| Man in't Veld, AJ | 1 |
| Guyatt, GH | 1 |
| Artman, M | 1 |
| Graham, TP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596] | Phase 4 | 63 participants (Actual) | Interventional | 2015-10-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for prazosin and Heart Diseases
| Article | Year |
|---|---|
[Cardiac therapy in the old patient].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Body Water; Calcium; Clonidine; Digitalis Glycos | 1979 |
Mono-aminergic receptors and blood pressure.
Topics: Adrenergic beta-Agonists; Blood Pressure; Catechol O-Methyltransferase; Cell Membrane; Clonidine; Do | 1985 |
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxi | 1986 |
1 trial available for prazosin and Heart Diseases
| Article | Year |
|---|---|
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxi | 1986 |
11 other studies available for prazosin and Heart Diseases
| Article | Year |
|---|---|
[Frequent errors in the therapy of heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biologic | 1982 |
[Effect on the peripheral circulation during treatment of cardiac insufficiency].
Topics: Blood Circulation; Cardiac Output; Heart; Heart Diseases; Hemodynamics; Humans; Nitrates; Nitroglyce | 1980 |
[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Coronary Disease; Dopamine; Epinep | 1980 |
[Short- and medium-term hemodynamic effects of prazosin in chronic refractory cardiac failure].
Topics: Adult; Aged; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1982 |
A possible mechanism for "tachyphylaxis' to prazosin in heart failure.
Topics: Angiotensin II; Heart Diseases; Hemodynamics; Humans; Prazosin; Quinazolines; Renin; Tachycardia | 1980 |
[Initial results of prazosin in the treatment of severe heart insufficiencies in children].
Topics: Adolescent; Child; Child, Preschool; Heart Diseases; Humans; Infant; Prazosin; Quinazolines | 1982 |
Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunction.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Cholesterol; Clofibrate; Diabetes Mellitus, Experim | 1994 |
alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Heart Diseases; Humans; Hypertension; Male; M | 1997 |
Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study.
Topics: Accidental Falls; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Cohort Studies; Comor | 2001 |
[Vasodilation treatment of heart insufficiency].
Topics: Heart Diseases; Humans; Hydralazine; Nitrites; Nitroprusside; Phentolamine; Prazosin; Vasodilator Ag | 1978 |
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemo | 1987 |